(Q36086816)
Statements
Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells (English)
P M McGowan
A Murray
N Synnott
N O'Donovan
L Flanagan
G Murphy
J Crown
1 reference